Elephas Company
Disruption in healthcare is accelerated by the need for improved diagnostics, novel pharmaceutical therapies, and the shift to patient-centric solutions. With the mission to tackle the massive oncology dilemma, Elephas is leading the way to change how clinicians treat cancer patients. By harnessing the latest advances in cancer biology, multimodal microscopy, and artificial intelligence, the Elephas platform has the ability to empower clinical decision-making and accelerate drug development.
Last Funding Type:
Series B
Funding Status:
Early Stage Venture
Headquarters:
Madison, Wisconsin, United States
Founded Date:
2020-05-01
Last Funding Date:
2022-09-06
Total Funding:
68500000.0
Investors Number:
6.0
Industry:
End-to-End Drug Development